Israeli COVID-19 treatment shows 100% survival rate – preliminary data
Not only have all the patients survived, according to Pluristem, but four of them showed improvement in respiratory parameters. Biologists work in a laboratory at Pluristem Therapeutics Inc. in Haifa – (photo credit: BAZ RATNER/REUTERS) Six critically ill coronavirus patients in Israel who are considered high-risk for mortality have been treated with Pluristem’s placenta-based cell-therapy product and…